Featuring a simple interface and flexibility, the EDI/HQ with AS2 Complete software enhances visibility of data errors, prevents chargebacks and decreases system monitoring time. The solution also has
The pharmaceutical company will leverage the platform for performance-based trial management processes, to track key performance indicators throughout the studies and monitor its strategic outsourcing model. PharmaPros strategic
Vaxfectin adjuvant has demonstrated to considerably increase the antibody and T-cell immune responses against antigens expressed from DNA vaccines in multiple animal models. The adjuvant will be used
Menactra vaccine prevents meningococcal meningitis and meningococcal diseases caused by Neisseria meningitidis’ strains A, C, Y and W-135, in individuals nine months of age to 55 years old.
Previously Milla held several senior positions within both pharmaceutical companies and the service sector, where he was responsible for both operational and corporate activities. CROMSOURCE chief executive officer
The study results include chronic lymphocytic leukemia (CLL), multiple myeloma (MM), indolent NHL and MCL lymphoid malignancies. Of the 43 abstracts, five include oral presentations, according to the
Gengos has served several companies and gained experience in areas such as corporate strategy, business development and transactions. ImmunoCellular founder and chief scientific officer John Yu said, "ImmunoCellular’s
The research will leverage the MolecularBreeding technology platform that offers new approach in developing vaccines targeting different HIV-1 strains. Altravax chief scientific officer Dr. Robert Whalen said the
Cancer Panels, which are available through Illumina and LifeTechnologies platforms, have the ability to screen and detect cancer causing genetic mutations from small amount of DNA. Cancer Panels
The trial will assess Erwinaze asparaginase-based therapy that is believed to play a vital role for ALL patients not left with any other treatment options and is expected
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.